2026-04-25T03:28:20Z https://www.pub.unibl.org/oai

oai:pub.unibl.org:39281 2026-01-06T04:43:30Z

Comparison of biosimilar CT-P10 and innovator rituximab in patients with rheumatoid arthritis: a randomized controlled Phase 3 trial /unibl/author/W Park https://www.unibl.org/sr-lat/fis/zaposlen/3403-ljubinka-bozic /unibl/author/Dragana Milakovic /unibl/author/A Berrocal Kasay /unibl/author/EC El-Khouri /unibl/author/F Irazoque-Palazuelos /unibl/author/FFC Molina /unibl/author/P Shesternya /unibl/author/P Miranda /unibl/author/FG Medina-Rodriguez 2018-08 Academic Article text 943 934 /unibl/sci/idNaucniRad:24617 STED Journal 2637-2150 STED Journal 2637-2150 W. Park, LJ. Božić, D. Milakovic, A. Berrocal Kasay, E. El-Khouri, F. Irazoque-Palazuelos, F. Molina, P. Shesternya, P. Miranda, F. Medina-Rodriguez, Comparison of biosimilar CT-P10 and innovator rituximab in patients with rheumatoid arthritis: a randomized controlled Phase 3 trial, STED Journal, pp. 934 - 943, Aug, 2018 https://www.pub.unibl.org/s/cir/item/39281